LD-2 disclosure · 4th Quarter - Termination
FABIANI & COMPANY ON BEHALF OF ALNYLAM PHARMACEUTICALS
via MARTIN GREEN
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Pharmaceuticals company
- Location
- District of Columbia · United States of America
Registrant
- Firm
- MARTIN GREEN
- Description
- Marketing and Government Relations
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Patenting of genetic sequences
LobbyistsMARTIN GREEN
Covered position (MARTIN GREEN): Deputy Chief of Staff, Rep. Mark Souder
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office
Copyright/Patent/Trademark
Patent reform legislation, including S. 510
LobbyistsMARTIN GREEN
Covered position (MARTIN GREEN): Deputy Chief of Staff, Rep. Mark Souder
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office